Isofol Medical AB (publ) publishes interim report, January–June 2022
GOTHENBURG, Sweden, August 23, 2022 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January–June 2022 is now available on the company's website, www.isofolmedical.com.The information in the press release is intended for investors. Second quarter, April–June 2022 · Net revenue amounted to TSEK 4,027 (7,333) and other revenue to TSEK 0 (0) · The result for the period amounted to TSEK -54,033 (-45,394) · Earnings per share amounted to SEK -0.33 (-0.48) · Cash and cash equivalents at June 30 amounted to TSEK 277,727 (